newsfilter
← Latest News
GlobeNewswire·

Bright Minds Biosciences to Present at the Oppenheimer 32nd Annual Healthcare Conference

VANCOUVER, British Columbia, March 08, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences ("Bright Minds," "BMB" or the "Company") (NASDAQ:DRUG) (CSE:DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsy